NO20076283L - Fremgangsmate for produksjon av lavmolekylaer vektheparin - Google Patents

Fremgangsmate for produksjon av lavmolekylaer vektheparin

Info

Publication number
NO20076283L
NO20076283L NO20076283A NO20076283A NO20076283L NO 20076283 L NO20076283 L NO 20076283L NO 20076283 A NO20076283 A NO 20076283A NO 20076283 A NO20076283 A NO 20076283A NO 20076283 L NO20076283 L NO 20076283L
Authority
NO
Norway
Prior art keywords
molecular weight
heparin
low molecular
production
weight heparin
Prior art date
Application number
NO20076283A
Other languages
English (en)
Inventor
Ragnar Flengsrud
Ole Rasmus Odegaard
Original Assignee
Uni For Miljo Og Biovitenskap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni For Miljo Og Biovitenskap filed Critical Uni For Miljo Og Biovitenskap
Publication of NO20076283L publication Critical patent/NO20076283L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28Substances of animal origin, e.g. gelatin or collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Oppfinnelsen vedrører en fremgangsmåte for fremstilling av en heparinblanding med meget lav molekylvekt (VLMWH) som har et VLMWH-innhold i forhold til totalt heparininnhold på minst 10 vekt-% idet nevnte fremgangsmåte omfatter kromatografisk eller kjemisk eller ved filtrering reduksjon av den relative andel av heparin med en molekylvekt over 8000Da i en heparinblanding ekstrahert fra et vaskulærisert marint ikke-pattedyr.
NO20076283A 2005-05-09 2007-12-06 Fremgangsmate for produksjon av lavmolekylaer vektheparin NO20076283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0509433.9A GB0509433D0 (en) 2005-05-09 2005-05-09 Method
PCT/GB2006/001690 WO2006120425A1 (en) 2005-05-09 2006-05-09 Process for the production of a low molecular weight heparin

Publications (1)

Publication Number Publication Date
NO20076283L true NO20076283L (no) 2008-02-06

Family

ID=34685309

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076283A NO20076283L (no) 2005-05-09 2007-12-06 Fremgangsmate for produksjon av lavmolekylaer vektheparin

Country Status (10)

Country Link
US (1) US20090105194A1 (no)
EP (1) EP1899384A1 (no)
JP (1) JP2008543987A (no)
CN (1) CN101218259B (no)
AU (1) AU2006245577A1 (no)
CA (1) CA2608136A1 (no)
GB (1) GB0509433D0 (no)
NO (1) NO20076283L (no)
NZ (1) NZ563821A (no)
WO (1) WO2006120425A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX344592B (es) 2005-12-13 2016-12-20 Exthera Medical Corp Metodo para eliminar extracorporalmente de la sangre un microbio patogeno, una celula inflamatoria o una proteina inflamatoria.
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
GB0812919D0 (en) * 2008-07-15 2008-08-20 Norwegian University Of Life Sciences Process
AU2010326028B2 (en) 2009-12-01 2014-10-02 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
WO2013188073A1 (en) 2012-06-13 2013-12-19 Exthera Medical, Llc Use of heparin and carbohydrates to treat cancer
WO2014209782A1 (en) 2013-06-24 2014-12-31 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
MX2017003723A (es) 2014-09-22 2017-06-30 Exthera Medical Corp Dispositivo de hemoperfusion portatil.
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
CN108179162A (zh) * 2018-01-16 2018-06-19 浙江海洋大学 一种低分子量肝素的制备方法
JP7424320B2 (ja) 2018-07-11 2024-01-30 味の素株式会社 腸内細菌科の細菌を用いてアルコール類およびアミン類を酵素によりスルフリル化する方法
KR20220005441A (ko) 2019-04-26 2022-01-13 라보라토리오스 파마슈티코스 로비, 에스.아. 접선유동여과법에 의해 저분자량 헤파린을 얻는 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
CN1284510A (zh) * 1999-08-17 2001-02-21 孙润伟 利用猪、牛、羊肺沉淀法生产肝素钠
US7618652B2 (en) * 2001-03-23 2009-11-17 Hepmarin As Glycosaminoglycan anticoagulants derived from fish
EP1524276A1 (en) * 2003-10-16 2005-04-20 Laboratori Derivati Organici S.P.A. Multistep process for the physical depolymerization of heparin and products obtained therefrom

Also Published As

Publication number Publication date
EP1899384A1 (en) 2008-03-19
AU2006245577A1 (en) 2006-11-16
NZ563821A (en) 2010-09-30
US20090105194A1 (en) 2009-04-23
GB0509433D0 (en) 2005-06-15
CA2608136A1 (en) 2006-11-16
JP2008543987A (ja) 2008-12-04
WO2006120425A1 (en) 2006-11-16
CN101218259B (zh) 2011-06-15
CN101218259A (zh) 2008-07-09

Similar Documents

Publication Publication Date Title
NO20076283L (no) Fremgangsmate for produksjon av lavmolekylaer vektheparin
AR059173A1 (es) Procedimiento para la obtencion de un etanol pobre en agua por deshidratacion con membranas y su empleo como educto en la elaboracion de etbe.
WO2010147686A3 (en) Methods of purifying small modular immunopharmaceutical proteins
NO20083057L (no) Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer
DK1888541T3 (da) Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander
DE602007009995D1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
WO2007113327A3 (en) Fungicide n-cyclopropyl-sulfonylamide derivatives
NO20100062L (no) Overflatereagert kalsiumkarbonat i kombinasjon med hydrofob adsorbent for vannbehandling
DE602007005024D1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
ATE448231T1 (de) Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen
WO2009115557A3 (en) Fungicide hydroximoyl-tetrazole derivatives
DE602006004160D1 (de) Niedertemperatur-Trocknungsverfahren zur Herstellung von arzneimittelhaltigen Polymerzusammensetzungen
TW200505837A (en) Novel compounds
TW200519075A (en) Novel compounds
WO2006009836A3 (en) Tdf-related compounds and analogs thereof
WO2008130953A3 (en) 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
DE502006007666D1 (de) Erialien
WO2008063781A3 (en) Chemical compounds as cannabinoid receptor ligands
EA201001044A1 (ru) Умами-активная фракция и способ её приготовления
NO20091108L (no) Fremgangsmate for fjerning av jodidforbindelse fra organisk syre
WO2010028338A3 (en) Novel compounds as cannabinoid receptor ligands
WO2010054024A3 (en) 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands
NO20091986L (no) Tykningsmiddelblanding
WO2007035872A3 (en) Tdf-related compounds and analogs thereof
BR112013020196A2 (pt) meio, método e uso de filtragem para purificação de fluidos, método para produção de composição ferro-prata e pó de ferro-prata

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application